You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0243 Data on the Impact of Anti-Cyclic-Citrulinnated Peptide Antibody Status (ANTI-CCP) on the Management of Patients with Early Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - prognosis, predictors and outcome
AB0243 Data on the Impact of Anti-Cyclic-Citrulinnated Peptide Antibody Status (ANTI-CCP) on the Management of Patients with Early Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 2014200
Jul 2014400
Aug 2014400
Sep 20141001
Oct 2014300
Nov 2014300
Dec 2014501
Jan 2015200
Feb 2015500
Mar 2015601
Apr 2015400
May 2015400
Jun 2015200
Jul 2015300
Aug 2015300
Sep 2015900
Oct 2015100
Nov 2015702
Dec 2015100
Jan 2016400
Feb 2016501
Mar 20161204
Apr 2016300
May 20161200
Jun 2016601
Jul 2016900
Aug 20161000
Sep 2016500
Oct 2016500
Nov 2016500
Dec 2016400
Jan 2017400
Feb 2017300
Mar 2017500
Apr 2017800
May 2017500
Jun 2017300
Jul 2017400
Aug 20171100
Sep 2017600
Oct 20171400
Nov 2017601
Dec 20171200
Jan 20182000
Feb 2018200
Mar 2018800
Apr 20181600
May 20182201
Jun 20181600
Jul 2018600
Aug 2018800
Sep 2018600
Nov 2018200
Dec 2018600
Mar 2019601
Apr 2019200
May 2019200
Dec 2019200
Apr 2020200
Jul 2020200
Aug 2020200
Sep 20201000
Oct 2020400
Nov 20201000
Dec 2020200
Jan 2021200
Feb 2021200
Mar 2021200
Apr 2021200
Oct 2021600
Nov 2021400
Dec 20211000
Feb 2022200
Apr 2022200
May 2022600
Jul 20222400
Aug 20221201
Sep 2022800
Oct 2022200
Nov 2022800
Dec 2022800
Feb 2023600
Mar 2023200
May 2023400
Jul 2023200
Aug 2023200
Sep 2023400
Nov 2023400
Dec 20231000
Feb 2024200
Mar 2024200
Total533015